Evommune, Inc. (EVMN) — Long-term Investment Intensity

Latest as of December 2025: 30.0%

Evommune, Inc. (EVMN) has a Long-term Investment Intensity of 30.0% as of December 2025. Long-term investments of $67.49 Million represent 30.0% of total assets of $224.95 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check EVMN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

30.0%
LT Investments / Total Assets

Long-term Investments

$67.49 Million
USD

Total Assets

$224.95 Million
USD

Country

USA
NYSE

Evommune, Inc. Long-term Investment Intensity (2025–2025)

This chart shows how Evommune, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 30.0%, reflecting long-term investments of $67.49 Million against total assets of $224.95 Million USD. For the complete balance sheet picture, see Evommune, Inc. assets under control.

Annual Long-term Investment Intensity for Evommune, Inc. (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Evommune, Inc. from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Evommune, Inc. for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 30.0% $67.49 Million $224.95 Million —
pp = percentage points